We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Innate Lymphoid Cells Analyzed at the Maternal-Fetal Interface

By LabMedica International staff writers
Posted on 26 May 2021
Preterm birth (PTB) is one of the major causes of neonatal morbidity and mortality worldwide. More...
It is commonly accepted that the act of giving birth is the final step in a proinflammatory signaling cascade, orchestrated by an intrauterine milieu coupled to hormonal cues.

The gestational period is comprised of decidualization, placentation and fetal development and requires uterine quiescence and the production of both anti- and proinflammatory cytokines from maternal and fetal cells. Throughout pregnancy, three distinct biological periods characterized by different immunological microenvironments occur.

A team of Medical Scientists at the University of Coimbra (Coimbra, Portugal) analyzed 15 full-term delivery samples and six preterm delivery samples (PTB). In the full-term group (FTB) peripheral blood was taken during routine blood analysis, on three occasions: 1st, 2nd and 3rd trimester. After delivery, peripheral blood, cord blood and placenta were collected. In the PTB group, peripheral blood samples were obtained on two occasions: before and 24 hours after treatment with progesterone.

The team dissected the placenta and the decidual tissue and lymphocytes were isolated from the decidua basalis and adjacent tissue (villi). Cells were counted on a Beckman Coulter AcT Diff automatic cell counter (Beckman Coulter, Brea, CA, USA) and isolated lymphocytes was placed in a cytometry tube and labeled with primary antibodies. Stained samples were acquired on a BD FACS Canto II flow cytometer (BD Biosciences, San Jose, CA, USA) Interleukin 17 (IL-17), IL-22, interferon gamma (IFN-γ) and IL-4 were determined by ELISA kits (Biolegend Legend Max, San Diego, CA, USA) and read on a Bio-Rad model 600 microplate reader (Bio-Rad, Hercules, CA, USA).

The investigators observed significantly increased relative frequencies of innate lymphoid cells 2 (ILC2) and ILC3 in the decidua, as well as an increase of ILC2 in cord blood samples in PTB group, compared to FTB samples. They also found a decrease in IFN-γ in peripheral blood samples of the PTB group, suggesting a functional withdrawal. Additionally, IL-4, IL-17, IL-22 levels were similar in PTB and FTB groups, denoting a relevant role in mediating labor.

The authors concluded that labor might be characterized by decreased tissue remodeling and repair functions, accompanied by a marked inflammatory response, due to high levels of ILC2 and ILC3. Also, the ELISA studies propose that labor might be characterized by a functional IFN- γ withdrawal. However, there was no significant decline in ILC1 population that could account for this result. The study was published on May 6, 2021 in the journal BMC Immunology.

Related Links:
University of Coimbra
Beckman Coulter
BD Biosciences
Biolegend Legend
Bio-Rad



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.